Santhera Pharmaceuticals Holding AG
SPHDF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$280.02M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $280.02 Million |
|---|---|
| Enterprise Value | $285.77 Million |
| Earnings per Share | $-3.78 |
| Beta | -0.28 |
| Outstanding Shares | 14,351,000 |
Return
| Return on Equity | 1579.02% |
|---|---|
| Return on Assets | -66.20% |
| Return on Invested Capital | -47.82% |
Valuation & Multiples
| P/E Ratio | -6.07 |
|---|---|
| PEG | 13.62 |
| Price to Sales | 1.83 |
| Price to Book Ratio | -18.3 |
| Enterprise Value to Revenue | 1.9 |
| Enterprise Value to EBIT | -6.04 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | -7.7 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$58.14 M
Consensus analyst estimateNext Earnings Call
Expected Date
April 29, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$44.51 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Santhera Pharmaceuticals Holding AG
78 employees
CEO: Orlando Oliveira
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America...